EyePoint Pharmaceuticals (EYPT) Shares Issued: 2011-2019
Historic Shares Issued for EyePoint Pharmaceuticals (EYPT) over the last 4 years, with Dec 2019 value amounting to -$6.5 million.
- EyePoint Pharmaceuticals' Shares Issued fell 15.91% to -$6.5 million in Q4 2019 from the same period last year, while for Dec 2019 it was $17.1 million, marking a year-over-year decrease of 74.55%. This contributed to the annual value of $163.3 million for FY2024, which is 27.79% down from last year.
- Per EyePoint Pharmaceuticals' latest filing, its Shares Issued stood at -$6.5 million for Q4 2019, which was down 2,562.12% from $264,000 recorded in Q1 2019.
- In the past 5 years, EyePoint Pharmaceuticals' Shares Issued registered a high of $34.5 million during Q2 2018, and its lowest value of -$6.5 million during Q4 2019.
- Over the past 3 years, EyePoint Pharmaceuticals' median Shares Issued value was $4.2 million (recorded in 2017), while the average stood at $7.6 million.
- Per our database at Business Quant, EyePoint Pharmaceuticals' Shares Issued surged by 61,090.00% in 2017 and then slumped by 192.22% in 2018.
- EyePoint Pharmaceuticals' Shares Issued (Quarterly) stood at $329,000 in 2015, then remained steady at $9,000 in 2016, then spiked by 10,600.00% to $6.1 million in 2017, then crashed by 192.22% to -$5.6 million in 2018, then decreased by 15.91% to -$6.5 million in 2019.
- Its Shares Issued stands at -$6.5 million for Q4 2019, versus $264,000 for Q1 2019 and -$5.6 million for Q4 2018.